Stericycle Inc. (SRCL) to Post Q4 2016 Earnings of $1.21 Per Share, Wedbush Forecasts
Stericycle Inc. (NASDAQ:SRCL) – Analysts at Wedbush reduced their Q4 2016 earnings estimates for shares of Stericycle in a research note issued to investors on Sunday. Wedbush analyst A. Kaschalk now forecasts that the brokerage will post earnings per share of $1.21 for the quarter, down from their previous estimate of $1.22. Wedbush has a “Neutral” rating and a $82.00 price target on the stock. Wedbush also issued estimates for Stericycle’s Q1 2017 earnings at $1.07 EPS, Q2 2017 earnings at $1.13 EPS, Q3 2017 earnings at $1.14 EPS, Q4 2017 earnings at $1.19 EPS, FY2017 earnings at $4.54 EPS, Q1 2018 earnings at $1.14 EPS, Q2 2018 earnings at $1.21 EPS, Q3 2018 earnings at $1.21 EPS and FY2018 earnings at $4.82 EPS.
Stericycle (NASDAQ:SRCL) last issued its quarterly earnings results on Thursday, October 27th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.17 by $0.07. The company earned $890.10 million during the quarter, compared to analyst estimates of $899.87 million. Stericycle had a net margin of 7.52% and a return on equity of 15.33%. The firm’s revenue was up 23.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.08 EPS.
SRCL has been the topic of several other reports. Macquarie assumed coverage on shares of Stericycle in a research note on Thursday, August 25th. They issued a “neutral” rating and a $96.00 price target on the stock. Jefferies Group reissued a “buy” rating and issued a $112.50 price objective (down from $125.00) on shares of Stericycle in a report on Wednesday, September 7th. Zacks Investment Research downgraded Stericycle from a “hold” rating to a “strong sell” rating in a report on Friday, October 7th. Imperial Capital downgraded Stericycle from an “in-line” rating to an “underperform” rating and decreased their price objective for the company from $100.00 to $93.50 in a report on Friday, July 29th. Finally, Wellington Shields downgraded Stericycle from an “accumulate” rating to a “hold” rating in a report on Friday, July 29th. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have given a buy rating to the company. Stericycle presently has a consensus rating of “Hold” and an average price target of $92.75.
Shares of Stericycle (NASDAQ:SRCL) opened at 74.89 on Tuesday. The stock has a market cap of $6.37 billion, a price-to-earnings ratio of 27.22 and a beta of 0.17. The company has a 50-day moving average of $76.00 and a 200 day moving average of $89.46. Stericycle has a one year low of $72.20 and a one year high of $128.94.
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Covington Capital Management boosted its position in shares of Stericycle by 9.8% in the third quarter. Covington Capital Management now owns 45,347 shares of the company’s stock worth $3,634,000 after buying an additional 4,060 shares in the last quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC boosted its position in shares of Stericycle by 18.2% in the third quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 11,037 shares of the company’s stock worth $894,000 after buying an additional 1,700 shares in the last quarter. Credit Suisse AG boosted its position in shares of Stericycle by 17.9% in the third quarter. Credit Suisse AG now owns 367,502 shares of the company’s stock worth $29,451,000 after buying an additional 55,877 shares in the last quarter. Dean Investment Associates LLC boosted its position in shares of Stericycle by 0.4% in the third quarter. Dean Investment Associates LLC now owns 40,165 shares of the company’s stock worth $3,219,000 after buying an additional 170 shares in the last quarter. Finally, Choate Investment Advisors boosted its position in shares of Stericycle by 15.9% in the third quarter. Choate Investment Advisors now owns 4,036 shares of the company’s stock worth $323,000 after buying an additional 555 shares in the last quarter. Institutional investors and hedge funds own 89.05% of the company’s stock.
In other Stericycle news, EVP John P. Schetz sold 1,398 shares of the stock in a transaction on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total value of $114,426.30. Following the completion of the transaction, the executive vice president now owns 1,088 shares in the company, valued at $89,052.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 3.30% of the stock is owned by company insiders.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.